 |
2008/2009
Research Report |
| |
Over the last three decades, we have awarded
approximately $90 million towards diabetes research. 30-page PDF
(Canadian Diabetes Association) |
| |
|
|
Research
Open Meeting - London |
| |
JDRF's Research Open Meetings are a great opportunity
for anyone with a connection to type 1 diabetes to find out about
the latest research into the condition (JDRF) |
| |
|
|
Diamyd® Phase
III Study approved by six European countries |
| |
Six European countries have approved the initiation
of a Phase III study with the Diamyd® diabetes vaccine for type 1 diabetes (Diamyd Medical) |
| |
|
|
Oramed
newsletter |
| |
Including: Developing a method for type 2 Diabetics
to swallow their daily insulin in a capsule form instead of injecting
themselves with painful needles did not happen overnight ... (Oramed) |
| |
|
|
FDA
Reports Nationwide Recall of Mislabeled ReliOn Insulin Syringes |
| |
The U.S. Food and Drug Administration is notifying
health care professionals and patients that Tyco Healthcare Group
LP (Covidien) is recalling one lot of ReliOn sterile, single-use,
disposable, hypodermic syringes with permanently affixed hypodermic
needles due to possible mislabeling (FDA) |
| |
|
|
Brain
glucagon-like peptide 1 signaling controls the onset of high-fat
diet-induced insulin resistance and reduces energy expenditure |
| |
We have demonstrated that in response to a HFD,
brain GLP-1 signaling induces hyperinsulinemia and insulin resistance
and decreases energy expenditure by reducing metabolic thermogenesis
and ambulatory activity (PubMed) |
| |
|
